NEW OPPORTUNITIES OF MONOTHERAPY WITH NEBILET FOR PATIENTS WITH CORONARY HEART DISEASE AND ARTERIAL HYPERTENSION
Nebilet – is a new β-adrenoceptor blocking agent possessing both superseleсtive and NO-producing properties. Efficacy and safety of nebilet monotherapy of 5 mg/d were evaluated for 20 patients with mild and moderate essential hypertension during 8 weeks of treatment. Positive hypotensive effect was...
Main Authors: | V. M. Loyfman, A. B. Ostrovsky, Z. P. Zhirnova, L. G. Horuk |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2000-12-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2240 |
Similar Items
-
ВЛИЯНИЕ ФУНКЦИ ПЕЧЕНИ НА ФАРМАКОКИНЕТИКУ β-БЛОКАТОРОВ У БОЛЬНЫХ С ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА И СОЧЕТАННОЙ ПАТОЛОГИЕЙ
by: Л. С. Литвинова, et al.
Published: (2013-08-01) -
THE GENE OF ALPHA2A-ADRENORECEPTOR AND ESSENTIAL ARTERIAL HYPERTENSION
by: T. A. Bairova, et al.
Published: (2014-11-01) -
RAMIPRIL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION AND ISCHEMIC HEART DISEASE
by: A. I. Chesnikova, et al.
Published: (2016-01-01) -
A double blind, randomized, controlled trial to study the effect of dexmedetomidine on hemodynamic and recovery responses during tracheal extubation
by: Barkha Bindu, et al.
Published: (2013-01-01) -
Sympathetic activity and arterial hypertension: potential for correction
by: O. Yu. Shayduk, et al.
Published: (2013-04-01)